99 results on '"A. Loupy"'
Search Results
2. High-dimensional mass cytometry identified circulating natural killer T-cell subsets associated with protection from cytomegalovirus infection in kidney transplant recipients
3. Concepts and applications of digital twins in healthcare and medicine
4. Evaluation of non-invasive biomarkers of kidney allograft rejection in a prospective multicenter unselected cohort study (EU-TRAIN)
5. Identification of liver transplant biopsy phenotypes associated with distinct liver biological markers and allograft survival
6. Report of the 2022 Banff Heart Concurrent: Focus on non-human leukocyte antigen antibodies in rejection and the pathology of “mixed” rejection
7. The Banff 2022 Kidney Meeting Work Plan: Data-driven refinement of the Banff Classification for renal allografts
8. The Banff 2022 Kidney Meeting Report: Reappraisal of microvascular inflammation and the role of biopsy-based transcript diagnostics
9. Challenges in the management of the kidney allograft: from decline to failure: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
10. Validation of the clinical utility of microRNA as noninvasive biomarkers of cardiac allograft rejection: A prospective longitudinal multicenter study
11. Subclinical rejection-free diagnostic after kidney transplantation using blood gene expression
12. Machine learning does not outperform traditional statistical modelling for kidney allograft failure prediction
13. Quantitative scoring of progression in transplant glomerulopathy using digital pathology may be superior to Banff cg scoring
14. Intermediate-term outcomes of complement inhibition for prevention of antibody-mediated rejection in immunologically high-risk heart allograft recipients
15. Thirty years of the International Banff Classification for Allograft Pathology: the past, present, and future of kidney transplant diagnostics
16. The emerging field of non–human leukocyte antigen antibodies in transplant medicine and beyond
17. Complement inhibition for prevention of antibody-mediated rejection in immunologically high-risk heart allograft recipients
18. Time-dependent lymphocyte count after transplantation is associated with higher risk of graft failure and death
19. Statistical performance of 16 posttransplant risk scores in a contemporary cohort of heart transplant recipients
20. Comparing the effects of two different strains of mycobacteria, Mycobacterium vaccae NCTC 11659 and M. vaccae ATCC 15483, on stress-resilient behaviors and lipid-immune signaling in rats
21. Trajectories of glomerular filtration rate and progression to end stage kidney disease after kidney transplantation
22. Intragraft gene expression in native kidney BK virus nephropathy versus T cell–mediated rejection: Prospects for molecular diagnosis and risk prediction
23. The XVth Banff Conference on Allograft Pathology the Banff Workshop Heart Report: Improving the diagnostic yield from endomyocardial biopsies and Quilty effect revisited
24. Effects of immunization with heat-killed Mycobacterium vaccae on autism spectrum disorder-like behavior and epileptogenesis in a rat model of comorbid autism and epilepsy
25. In situ multiplex immunofluorescence analysis of the inflammatory burden in kidney allograft rejection: A new tool to characterize the alloimmune response
26. Reverse transcriptase multiplex ligation-dependent probe amplification in endomyocardial biopsies for the diagnosis of cardiac allograft rejection
27. Treatment with a heat-killed preparation of Mycobacterium vaccae after fear conditioning enhances fear extinction in the fear-potentiated startle paradigm
28. Modeling graft loss in patients with donor-specific antibody at baseline using the Birmingham-Mayo (BirMay) predictor: Implications for clinical trials
29. Response to treatment and long-term outcomes in kidney transplant recipients with acute T cell–mediated rejection
30. An integrated molecular diagnostic report for heart transplant biopsies using an ensemble of diagnostic algorithms
31. Evidence that preimmunization with a heat-killed preparation of Mycobacterium vaccae reduces corticotropin-releasing hormone mRNA expression in the extended amygdala in a fear-potentiated startle paradigm
32. Value of monitoring circulating donor-reactive memory B cells to characterize antibody-mediated rejection after kidney transplantation
33. A phase I/II, double-blind, placebo-controlled study assessing safety and efficacy of C1 esterase inhibitor for prevention of delayed graft function in deceased donor kidney transplant recipients
34. Relevance of the Banff Human Organ Transplant Consensus Gene Panel for Detecting Antibody and T-Cell–Mediated Rejection of Kidney Allografts
35. Propensity score–based comparison of the graft failure risk between kidney transplant recipients of standard and expanded criteria donor grafts: Toward increasing the pool of marginal donors
36. T cell–mediated rejection is a major determinant of inflammation in scarred areas in kidney allografts
37. Antibody-mediated rejection: New approaches in prevention and management
38. Real Time Central Assessment of Kidney Transplant Indication Biopsies by Microarrays: The INTERCOMEX Study
39. Assessment of Tocilizumab (Anti–Interleukin-6 Receptor Monoclonal) as a Potential Treatment for Chronic Antibody-Mediated Rejection and Transplant Glomerulopathy in HLA-Sensitized Renal Allograft Recipients
40. Does the definition of chronic active T cell–mediated rejection need revisiting?
41. Validation of a prediction system for risk of kidney allograft failure in pediatric kidney transplant recipients: An international observational study
42. Longer-Term Clinical Outcomes From the THINKER and EXPANDER Trials of Transplantation of HCV-RNA+ Donor Kidneys Into Hepatitis C Virus-Negative Recipients
43. Temporary removal: Qualifying a novel clinical trial endpoint (iBOX) predictive of long-term kidney transplant outcomes
44. Banff 2013 Meeting Report: Inclusion of C4d-Negative Antibody-Mediated Rejection and Antibody-Associated Arterial Lesions
45. Pathologic classification of antibody-mediated rejection correlates with donor-specific antibodies and endothelial cell activation
46. Molecular Diagnosis of Antibody-Mediated Rejection in Human Kidney Transplants
47. mTOR signaling cascade: novel clinical implications in HLA and non-HLA antibody-mediated vasculopathies?
48. Kidney function following nephrectomy: Similitude and discrepancies between kidney cancer and living donation
49. (363) - Unsupervised Analysis of Gene Expression Data to Identify Lung Transplant Rejection Phenotypes
50. (48) - Banff Human Organ Transplant Panel for Detecting Antibody-Mediated Rejection in Lung Transplant Biopsies
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.